Alignment Healthcare, Inc. ALHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.27% | 37.57% | 42.17% | 46.40% | 47.58% |
| Total Other Revenue | -2.02% | 3.67% | 9.77% | 16.98% | 31.14% |
| Total Revenue | 35.87% | 37.21% | 41.81% | 46.06% | 47.39% |
| Cost of Revenue | 36.67% | 36.61% | 40.55% | 43.81% | 44.12% |
| Gross Profit | 30.29% | 41.58% | 51.38% | 64.23% | 75.37% |
| SG&A Expenses | 22.95% | 22.08% | 20.19% | 19.94% | 18.40% |
| Depreciation & Amortization | 12.68% | 13.57% | 12.58% | 13.44% | 8.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.90% | 34.69% | 37.76% | 40.37% | 40.25% |
| Operating Income | 684.24% | 351.04% | 156.69% | 115.42% | 104.48% |
| Income Before Tax | 251.61% | 180.84% | 121.82% | 99.25% | 87.67% |
| Income Tax Expenses | -160.17% | -159.62% | -42.86% | -4.76% | 32,640.00% |
| Earnings from Continuing Operations | 237.47% | 179.50% | 121.79% | 99.24% | 85.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -100.00% | -93.69% | 605.56% | 167.06% |
| Net Income | 238.97% | 179.88% | 121.85% | 99.43% | 85.56% |
| EBIT | 684.24% | 351.04% | 156.69% | 115.42% | 104.48% |
| EBITDA | 121.40% | 1,329.25% | 288.10% | 162.42% | 135.19% |
| EPS Basic | 224.24% | 173.00% | 120.83% | 99.37% | 85.35% |
| Normalized Basic EPS | 294.99% | 183.56% | 122.19% | 99.85% | 91.64% |
| EPS Diluted | 200.97% | 164.96% | 117.26% | 97.52% | 83.92% |
| Normalized Diluted EPS | 265.90% | 177.49% | 120.37% | 98.90% | 90.85% |
| Average Basic Shares Outstanding | 5.04% | 4.85% | 4.68% | 3.77% | 3.06% |
| Average Diluted Shares Outstanding | 4.20% | 6.57% | 8.44% | 6.53% | 5.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |